Drugs / GDC-0152
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00977067 | Jun 2007 → Nov 2009 | — | Genentech, Inc. | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GDC-0152 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00977067 ↗ |
| Action | Inhibit | “an IAP Protein Antagonist” NCT00977067 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL2063869 ↗ |
| Route | Intravenous | “Administered Intravenously” NCT00977067 ↗ |